Combining CAR T cells with existing immunotherapies may overcome resistance in glioblastomas

Genetically modified "hunter" T cells successfully migrated to and penetrated a deadly type of brain tumour known as glioblastoma (GBM) in a clinical trial of the new therapy, but the cells triggered an immunosuppressive tumour microenvironment and faced...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2tgtKfz
via IFTTT